Updated ESMO Clinical Practice Guideline on Cutaneous Melanoma
Marco Donia, Senior Consultant and Clinician-Scientist and Junior Research Group Leader at University of Copenhagen Herlev Hospital, shared a post by ESMO – European Society for Medical Oncology on LinkedIn, adding:
“Check out the new ESMO – European Society for Medical Oncology Recommendations for the treatment of Melanoma!
Honored to have worked on these Clinical Practice Guidelines with an amazing panel, led by Teresa Amaral, Olivier Michielin and Paolo A. Ascierto.”
Quoting ESMO – European Society for Medical Oncology‘s post:
“Updated ESMO Clinical Practice Guideline on Cutaneous Melanoma: New recommendations include neoadjuvant therapy for stage III melanoma and options for advanced disease based on (neo)adjuvant treatment, disease and patient characteristics.”
Cutaneous melanoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.
Authors: Amaral T, et al.
Marco Donia is a Senior Consultant, Clinician-Scientist and Junior Research Group Leader (TIL group) at the Department of Oncology and Center for Cancer Immune Therapy, University of Copenhagen Herlev Hospital, Denmark. He serves as an Associate Professor in Clinical Oncology at the University of Copenhagen. Donia is also a clinical oncologist treating patients with cancer immunotherapy. His research group is currently investigating new immune-regulatory circuits in PD-1/PD-L1 resistant tumors.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023